A new study suggests the next big breakthrough in cancer treatment might come from a familiar source.
Researchers at University of Florida found that patients with advanced lung or skin cancer who received a COVID-19 vaccine within 100 days of starting immunotherapy lived significantly longer than those who did not.
READ MORE: https://www.wcnc.com/article/news/local/connect-the-dots/covid-19-vaccine-immunotherapy-survival-rates-cancer-patients/275-beaf03c4-f7f4-449c-8d08-10c03b492a73
Well, it’s time to connect the dots when we make the news make sense. A new use for COVID vaccine technology is giving cancer patients hope. Our Lisa Washington shares while it’s not a cure, researchers say it may help the body fight cancer more effectively. A new study suggests the next big breakthrough in cancer treatment might come from a familiar source. Let’s connect the dots. Researchers at the University of Florida found that patients with advanced lung or skin cancer who received a COVID-19 vaccine within 100 days of starting immunotherapy lived significantly longer than those who did not. Researchers say the vaccine appears to act like a wake-up call for the immune system. It energizes immune cells which then respond more strongly. When immunotherapy is introduced, the result improved survival. Now this is still early data. The observational study will need to be followed by clinical trials that can prove cause and effect. If further trials confirm the finding, the implications are huge. A universal off the shelf cancer vaccine strategy that supports immunotherapy for many types of tumors. Researchers say it could revolutionize how we treat cancer, and that’s connecting the dots.
